ChengDu ShengNuo Biotec Co.,Ltd. (SHA:688117)

The AZEK Company Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	175.23	218.71	219.13	372.12	211.56	129.53
Trading Asset Securities	10.03	20.16	50	-	200	-
Cash & Short-Term Investments	185.26	238.86	269.13	372.12	411.56	129.53
Cash Growth	-28.81%	-11.25%	-27.68%	-9.58%	217.74%	24.28%
Accounts Receivable	173.94	125.2	115.89	119.16	111.73	106.08
Other Receivables	5.86	7.97	10.27	23.63	9.49	0.38
Receivables	179.79	133.17	126.16	142.79	121.22	106.46
Inventory	293.37	304.75	194.33	135.43	101.36	90.01
Prepaid Expenses	-	-	0.22	-	-	3.13
Other Current Assets	49.67	41.42	19.47	15.54	17.85	6.96
Total Current Assets	708.09	718.21	609.3	665.89	652.01	336.09
Property, Plant & Equipment	748.31	727.43	483.86	285.1	238.06	200.47
Long-Term Investments	67.44	111.04	94.43	55.69	9.9	-
Other Intangible Assets	55.97	40.2	35.48	36.3	36.48	22.52
Long-Term Deferred Tax Assets	10.27	9.48	4.04	3.84	3.46	3.42
Long-Term Deferred Charges	14.14	14.1	19.98	15.43	10.93	5.96
Other Long-Term Assets	60.67	27.44	68.64	45.75	5.78	24.52
Total Assets	1,665	1,648	1,316	1,108	956.62	592.98
Accounts Payable	115.77	108.54	51.05	28.55	7.83	20.62
Accrued Expenses	11.18	47.46	48.12	57.01	49.65	57.53
Short-Term Debt	192.64	200.16	37.03	50.41	30.05	-
Current Portion of Long-Term Debt	167.09	99.63	34.05	2	-	-
Current Portion of Leases	-	0.6	0.82	0.75	0.68	-
Current Income Taxes Payable	10.39	2.61	8.74	5.07	4.19	1.86
Current Unearned Revenue	26.48	26.89	9.53	17.99	14.59	15.73
Other Current Liabilities	58.56	57.58	51.93	63.21	55.48	49.28
Total Current Liabilities	582.11	543.46	241.28	225	162.46	145.02
Long-Term Debt	96.94	182.03	189.19	48.05	-	-
Long-Term Leases	-	-	0.6	1.42	2.17	-
Long-Term Unearned Revenue	19.6	4.09	4.56	5.72	6.85	10.39
Long-Term Deferred Tax Liabilities	-	-	-	1.07	-	-
Total Liabilities	698.65	729.58	435.63	281.27	171.48	155.41
Common Stock	112.42	112.42	112	80	80	60
Additional Paid-In Capital	390.37	389.59	379.22	408.36	407.25	140.94
Retained Earnings	463.45	416.33	388.71	338.37	297.89	236.64
Total Common Equity	966.25	918.34	879.93	826.74	785.14	437.57
Minority Interest	-	-0.02	0.17	-	-	-
Shareholders' Equity	966.25	918.32	880.1	826.74	785.14	437.57
Total Liabilities & Equity	1,665	1,648	1,316	1,108	956.62	592.98
Total Debt	456.67	482.42	261.7	102.64	32.89	-
Net Cash (Debt)	-271.41	-243.56	7.43	269.48	378.68	129.53
Net Cash Growth	-	-	-97.24%	-28.84%	192.35%	24.83%
Net Cash Per Share	-1.70	-1.53	0.05	1.73	2.68	1.10
Filing Date Shares Outstanding	157.39	157.39	156.8	156.8	156.8	117.6
Total Common Shares Outstanding	157.39	157.39	156.8	156.8	156.8	117.6
Working Capital	125.99	174.75	368.03	440.89	489.55	191.07
Book Value Per Share	6.14	5.83	5.61	5.27	5.01	3.72
Tangible Book Value	910.27	878.15	844.45	790.44	748.66	415.05
Tangible Book Value Per Share	5.78	5.58	5.39	5.04	4.77	3.53
Buildings	-	235.44	104.44	101.29	96.46	61.14
Machinery	-	318.26	254.46	44.74	198.53	169.25
Construction In Progress	-	348.97	274.37	83.64	50.06	69.43

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.